Patterns of Social Support Among Lymphoma Patients Considering Stem Cell Transplantation

Social Work in Health Care

Volumn 50, Issue 10, 2011, Pages 815-827

  Glover, Roni ^a   Shenoy, Pareen Jaideep ^a   Kharod, Grishma A ^a   Schaefer, Allison ^b   Bumpers, Kevin ^a   Berry, Jamillah T M ^c   Flowers, Christopher R ^d,e,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e EMORY UNIVERSITY   (United States)

^f Georgia Institute of Technology   (United States)

Author keywords

lymphoma; social support; stem cell transplantation; treatment delay

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; MALE; MIDDLE AGED; NONHODGKIN LYMPHOMA; PATIENT; PATIENT PARTICIPATION; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; SOCIAL SUPPORT; STEM CELL TRANSPLANTATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; FEMALE; GEORGIA; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENTS; RECURRENCE; SOCIAL SUPPORT; STEM CELL TRANSPLANTATION; YOUNG ADULT;

EID: 84857965498     PISSN: 00981389     EISSN: 1541034X     Source Type: Journal    
DOI: 10.1080/00981389.2011.595889     Document Type: Article

References (45)

1. Berry, J., Caplan, L., Davis, S., Minor, P., Counts-Spriggs, M., Glover, R. and Flowers, C. 2010. A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer, 116(3): 713-722.
2. Bhattacharya, J., Goldman, D. and Sood, N. 2003. The link between public and private insurance and HIV-related mortality. Journal of Health Economics, 22(6): 1105-1122.
3. Bradley, P.K. 2005. The delay and worry experience of African American women with breast cancer. Oncology Nursing Forum, 32(2): 243-249.
4. Brown, R., Dunn, S. and Butow, P. 1997. Meeting patient expectations in the cancer consultation. Annals of Oncology, 8(9): 877-882.
5. Cohen, S., Underwood, L.G. and Gottlieb, B.H., eds. 2000. Social Support Measurement and Intervention: A Guide for Health and Social Scientists, New York, NY: Oxford University Press.
6. Colon, E.A., Callies, A.L., Popkin, M.K. and McGlave, P.B. 1991. Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics, 32(4): 420-425.
7. DeNavas-Walt, C., Proctor, B.D., & Smith, J.C. (2010). Income, poverty, and health insurance coverage in the United States: 2009. Current Population Reports: Consumer Income. http://www.census.gov/prod/2010pubs/p60-238.pdf
8. Felix-Aaron, K., Moy, E., Kang, M., Patel, M., Chesley, F.D. and Clancy, C. 2005. Variation in quality of men's health care by race/ethnicity and social class. Medical Care, 43(3 SUPPL.): 172-181.
9. Fife, B.L., Huster, G.A., Cornetta, K.G., Kennedy, V.N., Akard, L.P. and Broun, E.R. 2000. Longitudinal study of adaptation to the stress of bone marrow transplantation. Journal of Clinical Oncology, 18(7): 1539-1549.
10. Flowers, C.R. and Armitage, J.O. 2010. A decade of progress in lymphoma: Advances and continuing challenges. Clinical Lymphoma, Myeloma, & Leukemia, 10(6): 414-423.
11. Flowers, C.R., Glover, R., Lonial, S. and Brawley, O.W. 2007. Racial differences in the incidence and outcomes for patients with hematological malignancies. Current Problems in Cancer, 31(3): 182-201.
12. Flowers, C.R., Sinha, R. and Vose, J.M. 2010. Improving outcomes for patients with diffuse large B-cell lymphoma. CA: A Cancer Journal for Clinicians, 60(6): 393-408.
13. Frick, E., Motzke, C., Fischer, N., Busch, R. and Bumeder, I. 2005. Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?. Psycho-Oncology, 14(9): 759-770.
14. Frick, E., Ramm, G., Bumeder, I., Schulz-Kindermann, F., Tyroller, M.Fischer, N. 2006. Social support and quality of life of patients prior to stem cell or bone marrow transplantation. British Journal of Health Psychology, 11(3): 451-462.
15. Frick, E., Rieg-Appleson, C., Tyroller, M. and Bumeder, I. 2005. Social support, affectivity, and the quality of life of patients and their support-givers prior to stem cell transplantation. Journal of Psychosocial Oncology, 23(4): 15-34.
16. Hann, D.M., Baker, F. and Denniston, M.M. 2003. Oncology professionals' communication with cancer patients about complementary therapy: A survey. Complement Therapies in Medicine, 11(3): 184-190.
17. House, J.S., Kahn, R.L., McLeod, J.D. and Williams, D. 1985. "Measures and concepts of social support". In Social Support and Health, Edited by: Cohen, S. and Syme, S. L. 83-108. San Diego, CA: Academic Press.
18. Huang, T., Shenoy, P.J., Sinha, R., Graiser, M., Bumpers, K. and Flowers, C.R. 2009. Development of a lymphoma enterprise architecture: A caBIG Silver level compliant lymphoma database system. Cancer Informatics, 8(Semantic Technologies Special Issue): 45-64.
19. Jacobsen, P.B., Sadler, I.J., Booth-Jones, M., Soety, E., Weitzner, M.A. and Fields, K.K. 2002. Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. Journal of Consulting and Clinical Psychology, 70(1): 235-240.
20. Lonial, S., Arellano, M., Hutcherson, D., Langston, A., Flowers, C.Heffner, L.T. 2006. Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & Lymphoma, 47(10): 2155-2162.
21. McCabe, P.M., Schneiderman, N., Field, T. and Wellens, A.R., eds. 2000. Stress, Coping, and Cardiovascular Disease, Mahwah, NJ: Lawrence Erlbaum Associates.
22. Mertler, C.A. and Vannatta, R.A. 2006. Advanced and Multivariate Statistical Methods: Practical Application and Interpretation, Glendale, CA: Pyrczak Publishing.
23. Mettler, M.V. 1993. Social support, information, expectancy, and adherence in outpatient cancer patients receiving chemotherapy, Texas Woman's University. Unpublished Ph.D.
24. Meyers, C.A., Weitzner, M., Byrne, K., Valentine, A., Champlin, R.E. and Przepiorka, D. 1994. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. Journal of Clinical Oncology, 12(4): 820-826.
25. Mitchell, J.M., Meehan, K.R., Kong, J. and Schulman, K.A. 1997. Access to bone marrow transplantation for leukemia and lymphoma: The role of sociodemographic factors. Journal of Clinical Oncology, 15(7): 2644-2651.
26. Moskowitz, C. H., Nimer, S.D., Zelenetz, A.D., Trippett, T., Hedrick, E.E.Filippa, D.A. 2001. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model. Blood, 97(3): 616-623.
27. National Comprehensive Cancer Network. 2010a. NCCN Clinical Practice Guidelines in Oncology-Hodgkin Lymphoma, Version 2.2010
28. National Comprehensive Cancer Network, Inc. (2010b). http://www.nccn.org
29. National Comprehensive Cancer Network. 2011a. NCCN Clinical Practice Guidelines in Oncology-Non-Hodgkin's Lymphomas, Version 2.2011
30. National Comprehensive Cancer Network, Inc. (2011b). http://www.nccn.org
31. Philip, T., Armitage, J.O., Spitzer, G., Chauvin, F., Jagannath, S.Cahn, J.-Y. 1987. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 316(24): 1493-1498.
32. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H.Bron, D. 1995. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333(23): 1540-1545.
33. Prounis, C. (2005). Marketing to professionals: Doctor-patient communication. Pharmaceutical Executive Magazine. http://pharmexec.findpharma.com/pharmexec/Professional+Marketing/Marketing-to-Professionals-Doctor-Patient-Communic/ArticleStandard/Article/detail/178166
34. Rao, R.S., Graubard, B.I., Breen, N. and Gastwirth, J.L. 2004. Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: Results from the 1998 National Health Interview Survey. Medical Care, 42(8): 789-800.
35. Richards, M.A., Smith, P., Ramirez, A.J., Fentiman, I.S. and Rubens, R.D. 1999. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. British Journal of Cancer, 79(5-6): 858-864.
36. Rodrigue, J.R., Pearman, T.P. and Moreb, J. 1999. Morbidity and mortality following bone marrow transplantation: Predictive utility of pre-BMT affective functioning, compliance, and social support stability. International Journal of Behavioral Medicine, 6(3): 241-254.
37. Sanders, T. and Skevington, S. 2004. Participation as an expression of patient uncertainty: An exploration of bowel cancer consultations. Psychooncology, 13(10): 675-688.
38. Shenoy, P.J., Malik, N., Nooka, A., Sinha, R., Ward, K.C.Brawley, O.W. 2010. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer, 117(11): 2530-2540.
39. Shenoy, P.J., Maggioncalda, A., Malik, N. and Flowers, C.R. 2011. Incidence patterns and outcomes for Hodgkin Lymphoma patients in the United States. Advances in Hematology, 2011(2011) doi:doi.10.1155/2011/725219
40. Tabbarah, M., Nowalk, M.P., Raymund, M., Jewell, I.K. and Zimmerman, R.K. 2005. Barriers and facilitators of colon cancer screening among patients at faith-based neighborhood health centers. Journal of Community Health, 30(1): 55-74.
41. Vose, J.M., Bierman, P.J., Enke, C., Hankins, J., Bociek, G.Lynch, J.C. 2005. Phase I Trial of Iodine-131 Tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma. Journal of Clinical Oncology, 23(3): 461-467.
42. Vose, J.M., Zhang, M.J., Rowlings, P.A., Lazarus, H.M., Bolwell, B.J.Freytes, C.O. 2001. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the autologous blood and marrow transplant registry. Journal of Clinical Oncology, 19(2): 406-413.
43. Waxler-Morrison, N., Hislop, T.G., Mears, B. and Kan, L. 1991. Effects of social relationships on survival for women with breast cancer: A prospective study. Social Science & Medicine, 33(2): 177-183.
44. Weis, J. 2003. Support groups for cancer patients. Support Care Cancer, 11(12): 763-768.
45. Westaway, M.S., Seager, J.R., Rheeder, P. and Van Zyl, D.G. 2005. The effects of social support on health, well-being and management of diabetes mellitus: A black South African perspective. Ethnicity & Health, 10(1): 73-89.